Skip to content

A Study to Assess the Effectiveness of Individualized Homeopathic Medicine in the Management of Acne Vulgaris Among Age Group 12 18 Yrs.

Effectiveness of Individualized Homeopathic Medicine in the Management of Acne Vulgaris Among Age Group 12 18 Yrs: A Non-Controlled Experimental Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/06/112122
Enrollment
39
Registered
2026-06-08
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L700- Acne vulgaris

Interventions

Intervention1: Homoeopathic Management: Individualized Homoeopathic Medicines Dose as per requirement of individual patient Frequency as per requirement of individual patient Route of administration o

Sponsors

Dr. G.D. Pol Foundation Y.M.T. Homoeopathic Medical College, Hospital And P.G. Institute
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: i. Clinically diagnosed patient of Acne vulgaris Grade I , Grade II ,Grade III . ii. Patient with Adolescents . iii. Patients of Acne Vulgaris of all genders.

Exclusion criteria

Exclusion criteria: i. Grade IV Acne vulgaris . ii. Suspected Immunocompromised patients. iii. Pregnant and Lactating females. iv. Unwilling Participants v. Patient taking steroid therapy or other acne treatment within 3 months of treatment. vi. Other Endocrinal comorbidity.

Design outcomes

Primary

MeasureTime frame
Global Acne Grading System ScoreTimepoint: baseline, 3 months and 6 months

Secondary

MeasureTime frame
Cardiff Acne Disability IndexTimepoint: baseline, 3 months, 6 months

Countries

India

Contacts

Public ContactDr Chintan Mehta

Dr. G.D. Pol Foundation, Y.M.T. Homoeopathic Medical College, Hospital and P.G. Institute

draafiyasheikh@gmail.com9920314197

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026